Pipeline
Project
Target
Indication
Target
Validation
Validation
PCC
IND-
Enabling
Enabling
Clinical
Early Stage
Early Stage
Clinical
Late Stage
Late Stage
Partner
Liver Delivery
RG002
Complement C3
Complement C3 mediated renal disease
RG001
Lp(a)
hyperlipidemia and atherosclerotic cardiovascular diseases
RG008
Undisclosed
Metabolic disease
Kidney Delivery
RG013
Undisclosed
Renal disease
RG014
Undisclosed
Renal disease
Adipose Targeting
RG015
Undisclosed
Metabolic disease